Latest news
Loading news…
Kanyos Bio
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Cambridge, Massachusetts, United States Founded 2015 1-10 employees For Profit
Kanyos Bio was founded with the goal of developing antigen-specific immune tolerance technology for two specific autoimmune indications.
Kanyos Bio was acquired by Anokion in 2019.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
1
Patents
0
3 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 7
- Active products
- 11
- Patents granted
- 0
- Trademarks
- 3
- IT spend
- $307K
Company Info
- Founded
- 2015
- Employees
- 1-10
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- HQ
- Cambridge, Massachusetts, United States
- Region
- Greater Boston Area, East Coast, New England
- Diversity spotlight
- Women Founded
- Exit date
- Sep 11, 2019
Signals & Scores
- Heat score
- Low
- Trend (7d)
- -0.3
- Trend (30d)
- -0.9
- Trend (90d)
- -0.7
1
professional contacts at Kanyos Bio
Contact execs at Kanyos Bio →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Kanyos Bio
Loading news…
FAQs about Kanyos Bio
People who checked this page also checked these
Browse the full Acquirezy directory.